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STUDY PROTOCOL Open Access
Music to improve sleep quality in adults
with depression-related insomnia
(MUSTAFI): study protocol for a randomized
controlled trial
Helle Nystrup Lund1*, Inge Nygaard Pedersen2, Søren Paaske Johnsen3, Agnieszka M. Heymann-Szlachcinska4,
Maryla Tuszewska5, Gustav Bizik6, Jens Ivar Larsen6, Eszter Kulhay6, Anelia Larsen6, Bettina Grønbech1,
Helle Østermark1, Heidi Borup7, Jan Brink Valentin3 and Jan Mainz8,9
Abstract
Background: Insomnia is a common sleep disorder for adults with depression, with major impact on their quality
of life. Previous trials suggest that listening to music may be helpful in the treatment of sleep disturbances in
healthy populations, including students and elderly. In addition, small studies with clinical populations of traumatized
refugees, adults with chronic insomnia and adults with depression insomnia add to the evidence base. However, the
impact of music listening in the treatment of depression related insomnia is not well documented.
Objective: To examine the efficacy of music listening on sleep quality, symptoms of depression, and quality of life in
adults with depression-related insomnia.
Method: A single-center randomized controlled trial (RCT) in a two-arm parallel-group design is conducted
and reported according to the CONSORT guidelines. The trial consists of an experimental group and a
standard care control group. Both groups receive standard treatment for depression following Danish clinical
guidelines in an outpatient psychiatry unit. The experimental group listens to music for a minimum of 30
minutes at bedtime for 4 weeks.
Discussion: This trial will provide information on the efficacy of music intervention as a non-pharmacological
intervention in the treatment of depression-related insomnia. This study will provide novel knowledge concerning
music medicine as an evidence-based treatment for depression.
Trial Registration: Clinicaltrials.gov. ID NCT03676491, registered on 19 September 2018.
Keywords: Music, insomnia, depression, sleep
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Background
Depression is a common health problem and an increas-
ing global burden. WHO has found unipolar depression
to be the third largest burden of disease globally in 2004
and is projected to rank first in 2030 [1]. A result of de-
pression is the loss of social and cognitive functions and
quality of life. One of the symptoms in depression is re-
duction in sleep quality (insomnia). Sleep disturbances
associated with depression include difficulties in falling
asleep and maintaining sleep. Cognitive behavioral ther-
apy (CBT) is recommended in clinical guidelines as first-
line treatment [2, 3]. Other treatment modalities for
sleep promotion include sleep hygiene, physical activity,
light therapy, relaxation techniques, music/nature
sounds and acupuncture [4]. Resolving sleep distur-
bances in patients with active or previous depression is
important as it may prevent worsening of symptoms and
relapse of depression [1].
Music listening is widely used as a sleep aid [5].
This practice is supported by a recent Cochrane re-
view concluding that music may be helpful in improv-
ing sleep quality in insomnia [5, 6]. The review
underlines that the small sample sizes of the studies
performed so far is a major limitation and concludes
that there is a need for additional intervention studies
concerning the effect of music listening on insomnia
on specific populations, including patients with
depression.
Moreover, a systematic review shows that music listen-
ing may reduce symptoms of depression in adults when
the music listening is conducted regularly for more than
3 weeks [7]. It was reported that patients responded
more when given a choice of music [5].
Giving a choice of music and offering a selection of
music with a variety to meet individual preferences are
both important factors highlighted in research [8, 9].
New research should offer a broad selection of calm
music to meet these criteria [6].
Patient-selected music has a risk of being too stimulat-
ing (effect-evoking or too dynamic, i.e. increasing pulse
and respiratory rate) [10]. Therefore, playlists designed
purposefully by music therapists are more likely to have
a sleep-inducing effect [8].
Music preference and culture have an influence on the
music-listening experience. The perceived quality of the
music depends on age, gender, preference, musical train-
ing, and cultural belonging [11]. Music listening is a
complex experience that influences the individual in
many ways, not strictly in relation to sleep and relax-
ation, but also in relation to wellbeing and sense of self
[11]. An improved sense of wellbeing may positively
affect the subjective feeling of restedness. The associ-
ation between wellbeing and quality of sleep is known
and reported in the literature [12].
This study aims to add knowledge into these domains,
investigating wellbeing by quality-of-life questionnaires
as well as subjective and objective measures of sleep
quality.
Feasibility study
We have carried out an observational feasibility study
introducing music listening as a non-pharmacological
intervention to improve sleep quality for patients with
depression [13]. Outpatients diagnosed with unipolar de-
pression and sleeping problems (n = 11) were asked to
listen to music for at least 30 minutes before going to
sleep every night for a period of 4 weeks. Music listening
was provided by a sound pillow equipped with an mp3
player containing 10 playlists of 30–60 minutes of relax-
ing music with different music styles (classical, easy lis-
tening, pop, rock) based on the literature of receptive
music therapy [14]. The study indicated signs of im-
proved sleep quality [13]. However, the study lacked a
control group.
Rationale for a randomized trial
Effective treatment modalities are in demand to supple-
ment existing treatment of insomnia in depression. The
positive effect of music on sleep quality has been re-
ported in a number of study settings with clinical and
nonclinical populations [6]. This study contributes to
the investigation of the efficacy of music listening in the
treatment of depression-related insomnia by combining
subjective measures (self-reported data) and objective
measures (accelerometer). In addition, a new app with
specially designed playlists makes a large selection of
music available to meet individual preferences.
Method – aim and hypothesis
The primary aim is to investigate the effect of music lis-
tening on sleep quality at 4 weeks follow-up. The sec-
ondary aim is to examine whether music listening is
effective in reducing symptoms of depression and im-
proving quality of life as well as improving sleep quality
at 8 weeks follow-up in patients with depression-related
insomnia.
The following hypothesis is tested
The controlled use of a sound pillow (Fig. 1) in combin-
ation with the Music Star app (Fig. 2) can serve as a
sleep aid in reducing depression-related sleep
disturbances.
Definitions
Music listening, music intervention, and music medicine
refer to the use of music as an intervention without an
active music therapist. In this protocol, music listening
implies listening to pre-recorded music.
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Insomnia, sleep disturbances and sleeping problems
refer to a broad understanding of the disorder. Symp-
toms include difficulties initiating and maintaining sleep.
The study is named MUsic STAr For Insomnia
(MUSTAFI).
Trial design
A single-center randomized controlled trial in a two-arm
parallel-group design is conducted from May 2018 to
December 2019 following the revised Consolidated Stan-
dards of Reporting Trials (CONSORT) guidelines [15].
The RCT includes two groups of participants, an experi-
mental group and a waitlist control group. Both groups
receive standard treatment for depression following na-
tional guidelines.
The duration of the intervention is 4 weeks. The par-
ticipants are followed for 8 weeks. Participation takes
place in the home of the patient. In addition, three
scheduled visits to the hospital in relation to the re-
search project are required. Baseline assessment is per-
formed on the starting day. Follow-up measurements are
performed after 4 and 8 weeks (Fig. 3).
The black element in the bottom left of Fig. 3 illus-
trates the intervention given as an option to the waitlist
control group. The participants may take home the
sound equipment for 4 weeks. There is no data collec-
tion involved. This has been added to the study for eth-
ical reasons and to limit drop out from the control
group [16]. The schedule for the trial is described in the
SPIRIT flow chart (Fig. 4) and the dimensions of the
study protocol have been described, adhering to the
SPIRIT checklist (Additional File 1).
Sample size
Based on a previous study, we assume that the mean de-
crease in Pittsburgh Sleep Quality Index (PSQI) scale is
3.04 (SD 2) points for the music intervention group and
2.04 (SD 1.67) points for the waitlist control group after
4 weeks of follow-up [17]. When estimating the sample
size, we assume that 25% of the eligible patients will be
willing to participate in the project. Based on the patient
flow in the outpatient clinic and the available resources
from the staff recruiting the patients, we assume that a
total of 120 participants can be recruited over a period
of 18 months. A dropout rate of 20% is expected. Hence,
a total of 100 randomized patients are expected to
complete the study. Based on the Satterwaite’s two-
sample t test and with a total of 100 patients (n = 50 per
group) the power of our study is estimated to be 76% (at
a confidence level of 5%).
Setting and participants
The study will be conducted at a single study site: the
Unit for Depression in Psychiatry at Aalborg University
Fig. 2 The Music Star is an app developed for iPad to select music
from a number of specially designed playlists. Each playlist is
represented by a colored triangle forming a star. (Photo courtesy of
Musikstjernen IVS)
Fig. 1 Selected solution-enabling music listening. A sound pillow is
a pillow with small internal speakers. The sound pillow features a
port through which to connect a player (Mp3/iPad/mobile phone).
The user selects the music on the player. (Photo courtesy of Sound Oasis)
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Hospital, Denmark. The participants are adult outpa-
tients aged 18–65 years in treatment for unipolar depres-
sion in the Northern part of Denmark.
Patients are referred to the unit for depression with dif-
ferent backgrounds. Some patients have not previously
been associated with psychiatry and are referred directly
from private practice with moderate or severe symptoms
of depression. Another group of patients are referred from
an inpatient unit. These patients are in recovery and have
a stabilized condition in need of follow-up treatment after
discharge. A third group of patients have been diagnosed
in previous contact or hospitalization and in need for
treatment after a recurrent depression.
Inclusion criteria
All patients are required to have a diagnosis of unipolar
depression (ICD-10 Depressive singular episode F32 or
Periodic depression F33) and sleeping problems identi-
fied by the Hamilton Depression Rating Scale (HAM-D)
by a score of at least 2 of a single item or at least 3 in
total for the three items (sleep items 4–6). In addition,
the patients should receive treatment according to
national guidelines for depression. This may include
pharmacological treatment, psychotherapy, psycho edu-
cation and electroconvulsive therapy. Participants are
eligible if within age 18–65, in stabilized pharmaco-
logical treatment, and having at least 4 weeks of
treatment.
Exclusion criteria
Exclusion criteria are unipolar depression with psychotic
episodes, substance or alcohol abuse, or sentence to
treatment by law. Patients will be excluded if they have
Fig. 3 Flow diagram of MUSTAFI phases, including enrolment, allocation, follow-up, and data analysis
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restless legs syndrome, obstructive sleep apnea, or other
organic sleep disorders as well as hearing loss. In
addition, patients with a dislike of music will be
excluded.
Recruitment
Patients are recruited in the Unit for Depression. Nurses,
psychiatrists, and psychologists use the screening tool 4
weeks after the beginning of treatment or after medical
treatment is stabilized. Participants are recruited through
posters, information by doctors and word of mouth in
the unit. After an initial assessment for eligibility, the pa-
tient is informed of the option to participate. The re-
cruitment takes place during group meetings or during
individual consultation in the unit. When the patient has
declared an interest to participate, the psychiatrist of the
patient fill out an inclusion document based on informa-
tion from the patient journal and his/her knowledge of
the patient. The document is forwarded to the research
leader. If the patient is eligible, the music therapist
makes an appointment to give detailed information on
participation in the research project.
Patients are included according to the inclusion and
exclusion criteria. The patient may be discharged during
participation in the research project and finalize as a
private person. If the increase in depression symptoms
results in hospitalization, the patient may continue par-
ticipation in agreement with caretakers in the unit. If the
patient is changing medication but is interested in par-
ticipation, the patient will be registered on a waitlist for
inclusion.
Informed consent
The patient may sign the informed consent after receiv-
ing oral and written information about the research pro-
ject. The information explains the aim and the
procedures of the research project, the use of sound
equipment and accelerometer and the rights as a partici-
pant in a scientific health study. The patient has the op-
tion to ask questions and if the patient need time to
consider the participation, the music therapist offer to
call the patient after 1 week and a new meeting is set up
for the signing of the informed consent. When the in-
formed consent is obtained and the inclusion criteria are
confirmed in the inclusion document, the music therap-
ist proceeds with the randomization. An additional con-
sent for collection and use of log file data from
accelerometer and the Music Star app is signed after
randomization. Documents of informed consent are kept
in a securely locked place.
Fig. 4 Schedule of enrolment, interventions, and assessments (Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) flow chart)
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Randomization
Randomization takes place when the inclusion document has
confirmed eligibility and the informed consent has been
signed following the regulations of the The North Denmark
Region Committee on Health Research Ethics Randomization
is carried out by the use of REDCap (Research Electronic
Data Capture) hosted at Aalborg University Hospital. RED-
Cap is a secure web-based application designed to support
data capture for research studies. The randomization will be
stratified according to age, i.e., under 30 years versus 30 years
and above. Randomization is performed using computer-
generated block randomization (random block sizes 2–8)
with 1:1 allocation between the intervention group and the
waitlist control group.
Procedure
The principal investigator is assigned to give information
on the research project to groups and individuals by team
members and coming to the unit by appointment. When
offering thorough information to obtain informed consent,
the music therapist takes the participant to the music
therapy clinic situated in a hospital building close by.
Experimental intervention
The music intervention consists of listening to music
with the use of a sound pillow, applying the music from
the Music Star app with special designed playlists. The
duration of music listening for 30 minutes minimum at
bedtime is guided by previous studies [6]. The principal
investigator HNL gives an oral guideline to music listen-
ing and use of sound equipment at the baseline appoint-
ment including how to adjust the volume. The pillow
speakers allow audio listening at very low volume. Ad-
herence to the intervention (30 minutes of bedtime
music) is monitored through log file data from The
Music Star app.
Instructions for the experimental intervention:
 It is required that you listen to music of your choice
from the Music Star for at least 30 minutes at
bedtime every night for 4 weeks. You may use the
Music Star during the night or in the early hours of
the morning if you wake up and have difficulty
falling asleep again.
 You may turn off the Music Star if you wake up
when the music plays and it is disturbing.
 The music will automatically stop when the playlist
ends after 30 or 60 minutes.
 You may use the Music Star in the daytime to assist
a rest. It is important only to use the Music Star for
relaxation and sleep.
 You are advised to listen to the different music
available to select your preferred playlists. You may
select a particular playlist to play every night. Some
people find that it is helpful to let a specific piece of
music be a signal for sleep initiation.
 Consider choosing music that you like and that may
help you fall asleep.
 You have to listen to music at night in the way it is
described for the research purpose, i.e. the sound
pillow in combination with the Music Star app.
 You may listen to your own music during the
daytime.
Instructions on the use of the sound equipment:
 Place the sound pillow on your bed (remove your own
pillow) and place the Music Star close to the bed on a
small table or chair for easy access during the night.
 Make sure that you have recharged the Music Star
during the day.
 If you have technical problems with the sound
equipment, you may contact the research leader by
phone from 9am to 12pm on weekdays.
Waitlist control group
The participants in the waitlist control group are asked
to continue their normal bedtime routines. They are not
given any instructions concerning music listening during
the 8 weeks. At the baseline appointment, they are in-
formed of the option to take home the music equipment
to test for 4 weeks at the end of the 8-week period.
Instruments
The data are derived from four questionnaires (three are
self-reported and one is scored by the psychiatrist, re-
searcher, or project nurse) and log file data from the accel-
erometer and from the Music Star app. The references
concerning validation of each instrument below are se-
lected according to their relevance to this study.
The Pittsburgh Sleep Quality Index (PSQI)
Is a commonly used questionnaire measuring self-
reported sleep habits in clinical populations in research
and clinical practice [18]. A Danish version of the ques-
tionnaire will be used. The items refer to sleep habits
and disturbances within the last month. The 19 items
are divided in seven domains: subjective sleep quality,
sleep latency, sleep duration, sleep efficiency, sleep dis-
turbances, daytime dysfunctions and use of antidepres-
sant agents. The seven components form a global score
ranging from 0 to 21, each component with a range
from 0 to 3. Buysse et al. reported a score of > 5 (indicat-
ing poor sleep) yielded a diagnostic sensitivity of 89.6%
and a specificity of 86.5% [18]. The scale shows good
homogeneity with an internal consistency, with α = 0.83.
Acceptable measures of validity were obtained through
the ability to distinguish between clinically distinct
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groups and comparing these with polysomnographic re-
sults. A score of > 5 is indicative of severe sleep difficul-
ties in at least two areas, and separating participants in
two categories “good” and “poor”. PSQI is validated in
psychiatric populations [19].
The Hamilton Depression Scale (HAM-D17)
The HAM-D17 consists of 17 items [20]. The items
cover the depressive state, the unspecific stress and
arousal symptoms, the suicidal thoughts, and lack of
insight. The respondent is asked to consider the last 3
days when responding.
Each item in the score is rated from 0 to 4 or 0 to 2,
the higher number indication an increase in the symp-
toms of depression. A guide to the Hamilton rating
questioning is used in combination with a rating sheet.
The total score indicates the severity of depression
symptoms graduating in four categories from unlikely
depression to severe depression, with 8–12 indicating
minimal depression, 13–17 indicating light depression,
18–24 indicating moderate depression, and 25–52 indi-
cating severe depression.
The 17-item version of the Hamilton Depression Rat-
ing Scale is validated [21].
The 5-item World Health Organization Well-Being Index
(WHO-5)
The 5-item World Health Organization Well-Being
Index (WHO-5) is among the most widely used ques-
tionnaires assessing subjective psychological well-being
[22]. It measures subjective quality of life based on posi-
tive mood (good spirits, relaxation), vitality (being active
and waking up fresh and rested), and general interest
(being interested in things). WHO-5 only contains posi-
tively phrased items. The WHO-5 items are: (1) ‘I have
felt cheerful and in good spirits’, (2) ‘I have felt calm and
relaxed’, (3) ‘I have felt active and vigorous’, (4) ‘I woke
up feeling fresh and rested’, and (5) ‘My daily life has
been filled with things that interest me’. The respondent
is asked to rate how well each of the five statements ap-
plies to him or her when considering the last 14 days.
Each of the five items is scored from 5 (all of the time)
to 0 (none of the time). The score therefore theoretically
ranges from zero (absence of well-being) to 25 (maximal
well-being). The use of WHO-5 as a measure of severity
of depression is validated [24).
The World Health Organization Quality of Life BREF
(WHOQOL-BREF)
In 1991, the World Health Organization initiated a pro-
ject with the aim of developing an international, cross-
culturally comparable QOL assessment instrument. “It
assesses the individual’s perceptions in the context of
their culture and value systems, and their personal goals,
standards and concerns. The WHOQOL instruments
were developed collaboratively in a number of centres
worldwide, and have been widely field-tested.” [25]. The
WHOQOL-BREF instrument is a shorter version of the
original 100-item self-report questionnaire, comprising 26
items measuring four domains: physical health, psycho-
logical health, social relationships, and environment. In
each question, the respondent reports his/her QOL in the
four domains on a 5-point Likert scale. A high score re-
flects the subjective experience of high QOL. The use of
WHO-QOL-BREF is validated [23].
The Music Star app
An app designed for iPad in 2014. The Music Star is a
self-explanatory user interface to select music from spe-
cifically designed playlists. Music therapists have selected
the music for the playlists. The app has a built-in log
function that registers each event when using the app.
The Music Star gives information from log files of music
played, time, and duration [24].
The 16 playlists of 30–60 minutes duration are repre-
sented by colored triangles forming a star. The four
playlists in shades of blue are the most quiet and simple
(lowest stimuli), the four playlists in shades of green in-
clude some variation and dynamics (moderate stimuli),
the four playlists in shades of red have more intensity
(highest stimuli). The grey triangles are intended to con-
tain playlists for specific purposes. A grey triangle con-
tains the only non-music playlist of ‘Summer Rain’
consisting of sounds of rain and bird sounds. The rain
sound adds a non-music track for the purpose of variety
in sound stimuli to meet individual preferences. Two
other grey triangles contain special designed playlists for
sleep. The classification of music is correlated to the de-
gree of complexity and tension of the musical stimulus
based on the taxonomy of music by Wärje & Bonde
[25]. The playlists in The Music Star are all categorized
in subdivisions of supportive music according to the tax-
onomy of music. The two sleep playlists have a 30- mi-
nute duration. Sleep 1 is a short version of a playlist
with music specially composed for relaxation and sleep,
including a male voice humming. Sleep 2 is a playlist
with a guitar-bass jazz duo playing slow ballads. Sleep 1
and 2 are included for meeting criteria of minimum dur-
ation and variety in the music selection. More than 100
music pieces in different genres are available in the
playlists.
Accelerometer
One triaxial accelerometer with on board memory
(Axivity Ax3, Newcastle upon Tyne, UK) placed in a
wrist bracelet will be used to measure arm movement
during the night. The measurement range was set to ±
8G with a sampling frequency of 25 Hz. A sleep analysis
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function using a generic algorithm will provide data on
sleep duration. Assessing sleep duration with an acceler-
ometer is validated [26].
Outcome measures
Primary outcome measure
We assess subjective quality of sleep through patient
self-reports using the PSQI to obtain data on psycho-
logical and emotional well-being.
The primary endpoint is defined as change of subject-
ive sleep quality from baseline at 4 weeks. Treatment
benefit is achieved when the PSQI score is decreased
with statistical significant change after the 4-week inter-
vention period.
Secondary outcome measures
We assess sleep quality using actigraphy to obtain ob-
jective sleep data. We assess symptoms of depression
using HAM-D17 to obtain data on the depressive state.
Finally, we assess quality of life using WHO-5 and
WHOQOL-BREF to obtain data on psychological well-
being considering mood, vitality, and interests (WHO-5)
and physical/psychological health, social engagement,
and environment (WHOQOL-BREF).
The secondary outcome measures are selected to ad-
dress these objectives (secondary outcome measure 2, 4, 6,
and 8). Measuring change from baseline at 8 weeks, assess
sustainability of results, and progression of symptoms over
time (secondary outcome measure 1,3,5,7, and 9).
The nine secondary endpoints are defined and listed
below:
1. Subjective sleep quality (PSQI): Change of sleep
quality from baseline at 8 weeks
2. Objective sleep quality (Actigraphy): Change of
sleep quality from baseline at 4 weeks
3. Objective sleep quality (Actigraphy): Change of
sleep quality from baseline at 8 weeks
4. Symptoms of depression (HAM-D17): Change of
depression level from baseline at 4 weeks
5. Symptoms of depression (HAM-D17): Change of
depression level from baseline at 8 weeks
6. Quality of life (WHO-5): Change of quality of life
from baseline at 4 weeks
7. Quality of life (WHO-5): Change of quality of life
from baseline at 8 weeks
8. Quality of life (WHOQOL-BREF): Change of
quality of life from baseline at 4 weeks
9. Quality of life (WHOQOL-BREF): Change of
quality of life from baseline at 8 weeks
All outcome measures are collected at baseline, after 4
weeks experimental/wait-list control and again after 4
weeks of follow-up. In addition, registration of
pharmacological treatment during the period of partici-
pation is included in the data collection.
Demographics
At baseline, demographic information including age, sex,
ethnicity, and partnership, children living at home,
handedness, diagnosis code for present depression, first
diagnosis of depression, and first psychiatric diagnosis
will be gathered. In addition, the participant may add
self-reported other disease and/or diagnosis. Work status
and education, alcohol use, and habitual use of music
for sleep will be registered.
Statistical methods
We initially perform a descriptive analysis on age, gen-
der, medication, illness duration etc. The two groups are
compared within groups and between groups using F-
tests and chi-squared tests. Additionally, we compare
the groups on outcome measures at baseline.
Data analysis for the RCT will be performed using
mixed effects linear regression with subject specific ran-
dom effects. The intervention group will be initially
compared with the control group on change of all out-
come measures after 4 and 8 weeks. Age and gender will
be added as covariates in all regression analyses.
Repeated-measures analysis of variance (RM-ANOVA)
will be used to compare results from baseline follow-up
one and follow-up two.
Finally, a descriptive analysis of the playlists is in-
cluded in the study, i.e. analysis of playlist preferences
(style, duration, time of day) in the group of patients
benefitting most from treatment compared to the group
of patients benefitting the least.
Blinding of the researchers performing the scorings
before and after the treatment as well as the subjects of
the study will not be possible. Patients will be anon-
ymized when analyzing data. All main analyses will be
carried out based on the intention-to-treat principle. In-
formation on adherence is obtained from the Music Star
log file data. Compliance rate will be part of the primary
study publication.
In case treatment is associated with dropout rate, we
will investigate differences in baseline characteristics be-
tween complete cases and patients that are lost to
follow-up. Any baseline characteristics that are signifi-
cantly different between these two groups will be used
as adjustment parameters in a sensitivity analysis of
music listening treatment on the primary outcome.
A multiple comparisons analysis will not be per-
formed, since the results of the analyses of music listen-
ing treatment on secondary outcome are purely
exploratory, in which case multiple testing analysis is
less important [26].
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Data collection and management
Data collection consists of several elements. The PSQI,
WHO-5, and WHOQOL-BREF are questionnaires filled
out exclusively by the participants. The HAM-D rating
is performed by the researcher (HNL). Data manage-
ment is carried out by the use of REDCap. Double data
entry is performed by research assistants.
Ethics
The study is approved by the local ethics committee (N-
20170055) and registered by the Danish Data Protection
Agency (ID 2017–236). A yearly report of adverse events
and other unintended effects of the trial will be obtained
by the local ethics committee.
Dissemination
Results of the study will be published in open-access
peer-reviewed scientific journals and presented at inter-
national scientific conferences regardless of the conclu-
sion. Broadcast of findings on Danish radio and TV
media will be planned through the study.
Discussion
The aim of this RCT is to investigate the efficacy of
music medicine compared with standard care. In order
to increase the clinical value of the research, the inclu-
sion and exclusion criteria have been selected to target a
group of depressive patients who have serious sleep dis-
turbances. This group of patients is less likely to respond
to interventions such as cognitive behavioral therapy.
Further, there is an augmented risk of relapse and sui-
cide [27, 28]. Sleep disturbances in depression result in a
slowdown of the recovery process for the individual and
this is costly for the individual and for the society [12].
If music medicine using the Music Star app combined
with a sound pillow shows to be effective in improving
sleep, it may not only have a positive effect on sleepless-
ness but also promote compliance with treatment and
increase overall functioning [27].
Limitations
The primary outcome measure is self-reported sleep.
Negative thinking is a symptom in depression that may
influence self-rating. The HAM-D17 rating is not per-
formed consistently by one person in all cases. Inter-
rater reliability has not been tested and may cause bias.
This study does not consider issues of comorbidity.
For some patients, sleep disturbances have been present
long before the onset of depression. In this study, sleep
disturbances are associated with depression although the
comorbid presentation of depression and insomnia may
be complex. The analysis of secondary outcomes is ex-
ploratory and thus more studies will be needed to con-
firm the results.
Trial status
Recruitment will take place from 23 May, 2018 to the
end of February 2020. By May 2019, 42 participants had
been included in the study. The current protocol is ver-
sion 3, dated 17 October, 2018.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13063-020-04247-9.
Additional file 1.
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